RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xuebiao Yao to Carcinoma, Renal Cell

Back to Details
This is a "connection" page, showing publications Xuebiao Yao has written about Carcinoma, Renal Cell.
Xuebiao Yao
Connection Strength
0.786
Carcinoma, Renal Cell
  1. Wang F, Wang LS, Gao YH, Yao XD. VHL enhances 9-cis-retinoic acid treatment by down-regulating retinoid X receptor a in renal cell carcinomas. Biochem Biophys Res Commun. 2020 03 05; 523(2):535-541.
    View in: PubMed
    Score: 0.692
  2. Zhang HL, Zhu Y, Wang CF, Yao XD, Zhang SL, Dai B, Shen YJ, Zhu YP, Shi GH, Ye DW. Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib. Int J Urol. 2011 Jun; 18(6):422-30.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support